Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service

Mean number of injections administered/ prescribed for adalimumab

This is assessed based on patient diary.

Time frame: Up to 12 months

Assessing Patient's overall satisfaction with AbbVie Care 2.0 program

Patient's overall satisfaction with AbbVie Care 2.0 program is scored at 1: Very good, 2: Good and 3: Less satisfying.

Time frame: At 12 months

Number of Sick Leaves

This is assessed by reviewing work time lost due to other reasons than health problems during previous last seven days.

Time frame: Up to 12 months

Time Spent by the Patient to Refill Prescription

This is assessed by reviewing the work productivity indicator over 12 months.

Time frame: Up to 12 months

Number of Hospital Inpatient Days

This is assessed by reviewing the use of health resources over 12 months.

Time frame: Up to 12 months

Number of Emergency Visits

This is assessed by reviewing the use of health resources over 12 months.

Time frame: Up to 12 months

Assessing Working Status

This is assessed by the proportion of patients employed.

Time frame: Up to 12 months

Proportion of patients with MPR>=80%

The variable MPR will be used, considering in the numerator the sum of days supply between start of observation (baseline) and last prescription dispensed (including the days of last prescription) and as denominator the number of days elapsed between baseline and last prescription dispensed (including the days of last prescription).

Time frame: At Month 6

Mean score of Treatment Satisfaction Questionnaire for Medication (TSQM)-II

This 14-point measure attempts to show that adherence is expected to be related with patients' satisfaction with therapy and such satisfaction can be a function of not only the effect of the treatment, but also the services offered. Domains include: Effectiveness, Side effects, Convenience and Global satisfaction.

Time frame: Up to Month 12

Mean Change in EuroQoL (EQ-5D) score

EQ-5D considers five attributes of quality of life evaluation, i.e., mobility, self-care, usual activity, pain/ discomfort, and anxiety/ depression.

Time frame: From Month 0 to Month 12

Number of Complementary Exams/ Techniques

This is assessed by reviewing the use of health resources over 12 months.

Time frame: Up to 12 months

Number of Hospitalizations

This is assessed by reviewing the use of health resources over 12 months.

Time frame: Up to 12 months

Time Spent by the Health Care Providers (HCPs) During Medical Appointments

This is assessed by reviewing the use of health resources over 12 months.

Time frame: Up to 12 months

Mean Change in Patient Activation Measure (PAM-13)

This is a powerful and reliable measure of patient activation. It is 13-item measure used to assess the patient knowledge, skill, and confidence for self-management.

Time frame: From Month 0 to Month 12

Mean Change in Beliefs about Medication Questionnaire (BMQ)

The BMQ comprises two sections: the BMQ-Specific, which assesses representations of medication prescribed for personal use and the BMQ-General, which assesses beliefs about medicines in general. This questionnaire is validated for use in Portugal.

Time frame: From Month 0 to Month 12

Change in Work Productivity and Activity Impairment- General Health (WPAI-GH)

WPA-GH assesses the impact of general health problem on work productivity and daily activities during the previous 7 days.

Time frame: From Month 0 to Month 12

Number of Outpatient Visits (in-office and remote) in Hospital Setting

This is assessed by reviewing the use of health resources over 12 months.

Time frame: Up to 12 months

Number of Days of Sick Leaves

This is assessed by reviewing work time lost due to health problems during previous seven days.

Time frame: Up to 12 months

Proportion of patients who are still on adalimumab after 6 and 12 months

This is used to assess persistence and it could be done using pharmacy refills.

Time frame: Up to 12 months